Shandong Xinhua Pharmaceutical Company Limited (0719.HK)
HKD 5.6
(0.72%)
HKD 5.6
(0.72%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 800.97 Million CNY | 46.07% |
| 2022 | 548.37 Million CNY | 56.46% |
| 2021 | 350.47 Million CNY | -24.55% |
| 2020 | 464.5 Million CNY | -21.36% |
| 2019 | 590.63 Million CNY | 13.01% |
| 2018 | 522.64 Million CNY | -43.89% |
| 2017 | 931.5 Million CNY | 831.5% |
| 2016 | 100 Million CNY | -73.56% |
| 2015 | 378.2 Million CNY | -40.53% |
| 2014 | 635.94 Million CNY | -28.45% |
| 2013 | 888.76 Million CNY | 23.84% |
| 2012 | 717.64 Million CNY | 236.42% |
| 2011 | 213.32 Million CNY | -22.58% |
| 2010 | 275.52 Million CNY | 2.05% |
| 2009 | 270 Million CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| 2007 | - CNY | 0.0% |
| 2006 | - CNY | 0.0% |
| 2005 | - CNY | 0.0% |
| 2004 | - CNY | -100.0% |
| 2003 | 200 Million CNY | 0.0% |
| 2002 | - CNY | -100.0% |
| 2001 | 150 Million CNY | 0.0% |
| 2000 | - CNY | -100.0% |
| 1999 | 3.56 Million CNY | -96.87% |
| 1998 | 113.94 Million CNY | 4.19% |
| 1997 | 109.36 Million CNY | 3.78% |
| 1996 | 105.37 Million CNY | 24.8% |
| 1995 | 84.43 Million CNY | -9.41% |
| 1994 | 93.2 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 798.38 Million CNY | -0.34% |
| 2024 Q3 | 791.04 Million CNY | -13.28% |
| 2024 Q2 | 913.35 Million CNY | 14.5% |
| 2023 FY | 800.97 Million CNY | 46.07% |
| 2023 Q1 | 1.04 Billion CNY | 91.38% |
| 2023 Q2 | 807.05 Million CNY | -23.1% |
| 2023 Q4 | 800.97 Million CNY | -0.21% |
| 2023 Q3 | 802.62 Million CNY | -0.55% |
| 2022 FY | 548.37 Million CNY | 56.46% |
| 2022 Q1 | 69.25 Million CNY | -80.24% |
| 2022 Q4 | 548.37 Million CNY | -2.25% |
| 2022 Q2 | 375.67 Million CNY | 442.45% |
| 2022 Q3 | 561.01 Million CNY | 49.34% |
| 2021 FY | 350.47 Million CNY | -24.55% |
| 2021 Q1 | 723.04 Million CNY | 55.66% |
| 2021 Q2 | 369.65 Million CNY | -48.87% |
| 2021 Q3 | 358.88 Million CNY | -2.91% |
| 2021 Q4 | 350.47 Million CNY | -2.34% |
| 2020 Q4 | 464.5 Million CNY | -2.2% |
| 2020 Q3 | 474.92 Million CNY | -2.27% |
| 2020 Q2 | 485.96 Million CNY | -9.87% |
| 2020 Q1 | 539.17 Million CNY | -8.71% |
| 2020 FY | 464.5 Million CNY | -21.36% |
| 2019 FY | 590.63 Million CNY | 13.01% |
| 2019 Q1 | 554.16 Million CNY | 6.03% |
| 2019 Q2 | 662.34 Million CNY | 19.52% |
| 2019 Q3 | 693.02 Million CNY | 4.63% |
| 2019 Q4 | 590.63 Million CNY | -14.77% |
| 2018 Q2 | 618.5 Million CNY | -33.53% |
| 2018 Q3 | 497 Million CNY | -19.64% |
| 2018 FY | 522.64 Million CNY | -43.89% |
| 2018 Q4 | 522.64 Million CNY | 5.16% |
| 2018 Q1 | 930.5 Million CNY | -0.11% |
| 2017 FY | 931.5 Million CNY | 831.5% |
| 2017 Q4 | 931.5 Million CNY | -1.9% |
| 2017 Q3 | 949.5 Million CNY | 41.72% |
| 2017 Q2 | 670 Million CNY | 570.0% |
| 2017 Q1 | 100 Million CNY | 0.0% |
| 2016 FY | 100 Million CNY | -73.56% |
| 2016 Q4 | 100 Million CNY | 0.0% |
| 2016 Q1 | 333.2 Million CNY | -11.9% |
| 2016 Q2 | 330 Million CNY | -0.96% |
| 2016 Q3 | 100 Million CNY | -69.7% |
| 2015 Q1 | 632.56 Million CNY | -0.53% |
| 2015 Q4 | 378.2 Million CNY | -55.3% |
| 2015 FY | 378.2 Million CNY | -40.53% |
| 2015 Q3 | 846.04 Million CNY | 21.86% |
| 2015 Q2 | 694.25 Million CNY | 9.75% |
| 2014 Q1 | 1.07 Billion CNY | 21.49% |
| 2014 Q3 | 878.33 Million CNY | -17.77% |
| 2014 Q4 | 635.94 Million CNY | -27.6% |
| 2014 FY | 635.94 Million CNY | -28.45% |
| 2014 Q2 | 1.06 Billion CNY | -1.08% |
| 2013 Q4 | 888.76 Million CNY | 9.1% |
| 2013 FY | 888.76 Million CNY | 23.84% |
| 2013 Q3 | 814.63 Million CNY | 3.69% |
| 2013 Q2 | 785.62 Million CNY | -16.19% |
| 2013 Q1 | 937.37 Million CNY | 30.62% |
| 2012 FY | 717.64 Million CNY | 236.42% |
| 2012 Q2 | 290.09 Million CNY | -0.76% |
| 2012 Q1 | 292.31 Million CNY | 37.03% |
| 2012 Q3 | 214.09 Million CNY | -26.2% |
| 2012 Q4 | 717.64 Million CNY | 235.2% |
| 2011 Q2 | 394.94 Million CNY | 5.24% |
| 2011 FY | 213.32 Million CNY | -22.58% |
| 2011 Q4 | 213.32 Million CNY | -45.65% |
| 2011 Q3 | 392.46 Million CNY | -0.63% |
| 2011 Q1 | 375.26 Million CNY | 36.2% |
| 2010 Q2 | 350 Million CNY | 0.0% |
| 2010 Q3 | 425.9 Million CNY | 21.69% |
| 2010 Q4 | 275.52 Million CNY | -35.31% |
| 2010 Q1 | 350 Million CNY | 29.63% |
| 2010 FY | 275.52 Million CNY | 2.05% |
| 2009 Q2 | 60 Million CNY | 0.0% |
| 2009 FY | 270 Million CNY | 0.0% |
| 2009 Q3 | 100 Million CNY | 66.67% |
| 2009 Q1 | - CNY | 0.0% |
| 2009 Q4 | 270 Million CNY | 170.0% |
| 2008 Q2 | - CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |
| 2008 Q1 | - CNY | 0.0% |
| 2008 Q4 | - CNY | 0.0% |
| 2008 Q3 | - CNY | 0.0% |
| 2007 FY | - CNY | 0.0% |
| 2007 Q3 | - CNY | 0.0% |
| 2007 Q1 | - CNY | 0.0% |
| 2007 Q2 | - CNY | 0.0% |
| 2007 Q4 | - CNY | 0.0% |
| 2006 Q2 | - CNY | 0.0% |
| 2006 Q1 | - CNY | 0.0% |
| 2006 Q4 | - CNY | 0.0% |
| 2006 FY | - CNY | 0.0% |
| 2006 Q3 | - CNY | 0.0% |
| 2005 Q2 | - CNY | 0.0% |
| 2005 Q4 | - CNY | 0.0% |
| 2005 Q3 | - CNY | 0.0% |
| 2005 Q1 | - CNY | 0.0% |
| 2005 FY | - CNY | 0.0% |
| 2004 Q4 | - CNY | -100.0% |
| 2004 Q1 | 200 Million CNY | 0.0% |
| 2004 Q3 | 250 Million CNY | 0.0% |
| 2004 FY | - CNY | -100.0% |
| 2004 Q2 | 250 Million CNY | 25.0% |
| 2003 FY | 200 Million CNY | 0.0% |
| 2003 Q1 | - CNY | 0.0% |
| 2003 Q2 | - CNY | 0.0% |
| 2003 Q3 | 200 Million CNY | 0.0% |
| 2003 Q4 | 200 Million CNY | 0.0% |
| 2002 Q3 | 200 Million CNY | 0.0% |
| 2002 Q1 | 150 Million CNY | 0.0% |
| 2002 FY | - CNY | -100.0% |
| 2002 Q2 | 200 Million CNY | 33.33% |
| 2002 Q4 | - CNY | -100.0% |
| 2001 Q4 | 150 Million CNY | 0.0% |
| 2001 Q2 | - CNY | 0.0% |
| 2001 FY | 150 Million CNY | 0.0% |
| 2000 FY | - CNY | -100.0% |
| 2000 Q4 | - CNY | 0.0% |
| 2000 Q2 | - CNY | 0.0% |
| 1999 FY | 3.56 Million CNY | -96.87% |
| 1999 Q4 | 3.56 Million CNY | 0.0% |
| 1999 Q2 | 28.37 Million CNY | 0.0% |
| 1998 Q4 | 113.94 Million CNY | 0.0% |
| 1998 FY | 113.94 Million CNY | 4.19% |
| 1998 Q2 | 109.36 Million CNY | 0.0% |
| 1997 Q4 | 109.36 Million CNY | 0.0% |
| 1997 FY | 109.36 Million CNY | 3.78% |
| 1997 Q2 | - CNY | 0.0% |
| 1996 FY | 105.37 Million CNY | 24.8% |
| 1996 Q4 | 105.37 Million CNY | 0.0% |
| 1995 FY | 84.43 Million CNY | -9.41% |
| 1994 FY | 93.2 Million CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 2.07 Million HKD | -38538.648% |
| Grand Pharmaceutical Group Limited | 990.02 Million HKD | 19.095% |
| Extrawell Pharmaceutical Holdings Limited | 117.12 Million HKD | -583.872% |
| Wai Yuen Tong Medicine Holdings Limited | 276.2 Million HKD | -190.0% |
| Qianhai Health Holdings Limited | - HKD | -Infinity% |
| Lee's Pharmaceutical Holdings Limited | 70.63 Million HKD | -1033.953% |
| Essex Bio-Technology Limited | 36.05 Million HKD | -2121.441% |
| Tongfang Kontafarma Holdings Limited | 12.8 Million HKD | -6157.158% |
| PuraPharm Corporation Limited | 81.09 Million HKD | -887.729% |
| SSY Group Limited | 1.94 Billion HKD | 58.873% |
| JBM (Healthcare) Limited | 43.8 Million HKD | -1728.719% |
| Jacobson Pharma Corporation Limited | 592.2 Million HKD | -35.255% |
| China Resources Pharmaceutical Group Limited | 16.61 Billion HKD | 95.18% |